SK bioscience Co.,Ltd. (KRX:302440)

SK bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,345,240	3,778,446	3,948,704	5,528,451	5,643,627	17,212,500
Market Cap Growth	-7.98%	-4.31%	-28.57%	-2.04%	-67.21%	-
Enterprise Value	3,157,581	3,423,836	2,813,918	4,326,779	-	-
Last Close Price	42650.00	48200.00	50400.00	72000.00	73500.00	225000.00
PE Ratio	-	-	-	247.72	46.09	48.47
Forward PE	-	-	-	-	24.69	23.37
PS Ratio	5.14	5.80	14.76	14.96	12.36	18.53
PB Ratio	1.64	1.85	1.95	3.25	3.24	10.75
P/TBV Ratio	2.01	2.27	2.34	3.27	3.25	10.78
P/FCF Ratio	-	-	-	-	-	34.87
P/OCF Ratio	32.63	36.86	-	188.39	-	32.08
EV/Sales Ratio	4.85	5.26	10.52	11.71	-	-
EV/EBITDA Ratio	-	-	-	189.96	-	-
Debt / Equity Ratio	0.23	0.23	0.19	0.01	0.07	0.07
Debt / EBITDA Ratio	-	-	-	0.90	0.80	0.22
Debt / FCF Ratio	-	-	-	-	-	0.22
Net Debt / Equity Ratio	-0.21	-0.21	-0.38	-0.74	-0.78	-0.96
Net Debt / EBITDA Ratio	13.43	13.43	8.58	-55.04	-9.61	-3.12
Net Debt / FCF Ratio	5.41	5.41	2.62	88.81	6.91	-3.12
Asset Turnover	0.23	0.23	0.11	0.19	0.22	-
Inventory Turnover	2.88	2.88	1.63	1.70	1.35	-
Quick Ratio	3.19	3.19	4.34	9.56	4.13	3.68
Current Ratio	3.82	3.82	5.08	10.20	4.69	4.00
Return on Equity (ROE)	-2.77%	-2.77%	-2.69%	1.29%	7.33%	-
Return on Assets (ROA)	-2.66%	-2.66%	-3.69%	-0.38%	3.38%	-
Return on Invested Capital (ROIC)	-8.02%	-8.64%	-16.21%	-2.91%	45.57%	577.65%
Return on Capital Employed (ROCE)	-4.70%	-4.70%	-5.50%	-0.70%	6.50%	28.70%
Earnings Yield	-1.72%	-1.52%	-1.36%	0.40%	2.17%	2.06%
FCF Yield	-2.41%	-2.13%	-7.41%	-0.26%	-3.51%	2.87%
Buyback Yield / Dilution	-1.49%	-1.49%	-0.23%	0.01%	-4.32%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.